Biofargo News & Blog

In the news (June 2026): Phase 3 RASolute 302 results for RMC-6236 (daraxonrasib) in previously treated metastatic pancreatic cancer were presented at the 2026 ASCO Annual Meeting, where the data drew a...

We tend to lump all ultraviolet (UV) light together — the same invisible radiation that tans your skin at the beach also powers the germicidal lamps used to sterilize hospital rooms, water...

Intravenous (IV) dosing through the lateral tail vein is one of the most common — and most frustrating — techniques in preclinical mouse research. When it works, it's fast and clean. When...

Choosing a detergent for membrane protein work sounds like a small decision, but it shapes everything downstream — whether your protein stays folded, whether you can run isoelectric focusing, and whether you...

Tools and reagents to help your lab set up Hantavirus detection — from sample to result. Who We Are Biofargo is a distributor based in Richmond, Virginia. We work with public health...

If you’ve ever tried to genotype a colony of CRISPR-edited mice with a generic SYBR Green qPCR mix, you already know the answer: it doesn’t work well. The clusters are fuzzy, heterozygotes...